Production (Stage)
Rakovina Therapeutics Inc.
RKV.V
TSX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -53.04% | -29.35% | -11.47% | 2.02% | 9.91% |
| Total Depreciation and Amortization | -1.21% | -0.58% | -0.90% | -1.73% | -3.66% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 18.97% | 42.37% | 28.01% | -4.37% | -29.39% |
| Change in Net Operating Assets | -2,584.18% | 182.20% | 436.29% | 438.24% | -75.16% |
| Cash from Operations | -102.32% | -26.39% | 30.82% | 7.95% | 6.23% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -100.00% | -100.00% | -- | -- |
| Total Debt Repaid | -- | -- | 200.00% | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -67.02% | 28.37% | -- | -- | -- |
| Cash from Financing | 227.15% | 34.18% | 15.54% | -- | 61,252.94% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 282.61% | -5.73% | 122.74% | 78.57% | 77.01% |